Anticoagulation-Associated Bleeding in Patients Screened for Atrial Fibrillation versus Usual Care-A Post Hoc Analysis from the LOOP Study.

The increase in bleeding risk was robust to adjustment for hemorrhagic risk factors, though this was not the case in both randomization groups: in the control group, the risk rose almost threefold, while the 30% increase in the ILR group did not reach statistical significance.

also in 111,027 other papers